Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
EDUMICILOR is a monocentric prospective pilot study for patients with inflammatory bowel disease (IBD).
During the study, patients will participate in an online therapeutic education program.
They will first have an appointment with a nurse to establish a personalized educational diagnosis. Then they will participate in the online therapeutic education program for about 6 months (depends on the educational needs, expectations and patient's availabilities).
The main objective of this study is to assess the feasibility of an online therapeutic education program for IBD patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| EDUMICILOR | Other | Patients will participate in the online therapeutic education program for about 6 months |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| EDUMICILOR | Other | Patients will participate in the online therapeutic education program for about 6 months |
|
| Measure | Description | Time Frame |
|---|---|---|
| Frequency of participation in the online therapeutic education program | Patients must participate in at least 80% of therapeutic education program sessions and connect to at least one video or one serious game. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Score of the Crohn and Colitis Knowledge Score | The Crohn and Colitis Knowledge Score will assess the impact of the online therapeutic education program on achieving educational objectives. | 6 months |
| Score of the short Inflammatory Bowel Disease Questionnaire (short-IBDQ) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Muriel Veltin | Contact | 0033383154187 | muriel.veltin@micilor.com |
| Name | Affiliation | Role |
|---|---|---|
| Muriel Veltin | Central Hospital, Nancy, France | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHRU Nancy | Recruiting | Nancy | France |
Not provided
| ID | Term |
|---|---|
| D003424 | Crohn Disease |
| D003093 | Colitis, Ulcerative |
| ID | Term |
|---|---|
| D015212 | Inflammatory Bowel Diseases |
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The short-IBDQ will assess the quality of life before and after the online therapeutic education program. |
| 6 months |
| Score of the Inflammatory Bowel Disease Disability Index (IBD Disability Index) | The IBD Disability index will be used to assess disability before and after the online therapeutic education program. | 6 months |
| Score of the Hospital Anxiety and Depression Scale | The Hospital Anxiety and Depression scale will assess the anxiety and depression level before and after the online therapeutic education program. | 6 months |
| Score of the Girerd Scale | The Girerd Scale will be used to assess the level of adherence to prescribed drugs before and after the online therapeutic education program. | 6 months |
| Score of a satisfaction survey on the online therapeutic education program | This survey will identify the advantages and disadvantages of an online therapeutic education program. | 6 months |
| D007410 | Intestinal Diseases |
| D003092 | Colitis |
| D003108 | Colonic Diseases |